Market Overview:
The global ST2 biomarker market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cardiovascular diseases, rising awareness about early diagnosis and treatment of heart failure, and technological advancements in the field of diagnostics. On the basis of application, hospitals are expected to account for a larger share of the global ST2 biomarker market than diagnostic centres, ambulatory surgical centres, and others duringthe forecast period. This can be attributedto th efact that hospitals are equipped with advanced diagnostic facilities that enable them to detect early signs or symptoms o fcardiovascular diseasesand offer timely treatment t o patients .
Product Definition:
ST2 is a biomarker that is associated with inflammation. It has been shown to be a predictor of heart failure and mortality in patients with heart failure.
ELISA Based ST2 Biomarker:
ELISA-based ST2 biomarker is a protein that acts as an indicator of systemic autoimmune disease. The ELISA test is used to detect the presence of anti-DNA antibody in the blood sample. Presence or absence of ELISA positive/negative results in favor or against autoimmune diseases, respectively.
Immunochromatography Based ST2 Biomarker:
In addition, increasing geriatric population base with high susceptibility to develop these disorders coupled with rising adoption of unhealthy lifestyle habits are some key factors driving the market growth.
Application Insights:
The hospital segment dominated the global market in 2017 and is expected to maintain its dominance over the forecast period. The rising prevalence of chronic diseases such as cancer, respiratory disorders, diabetes mellitus, cardiovascular diseases and autoimmune disorders has led to an increase in demand for diagnostic tests. As a result, hospitals are at the forefront of adopting advanced technologies that help diagnose disease faster with higher accuracy. This trend is expected to continue over the forecast period owing to increasing investments by governments in healthcare infrastructure development along with growing emphasis on improving population health through early diagnosis.
The others application segment includes laboratories and other clinical facilities that perform diagnostic testing services other than hospitals or clinics (for example; private practices). These facilities use point-of-care testing methods due to their ease of use compared to traditional laboratory techniques.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for technologically advanced tests are some of the factors responsible for its large share. Moreover, increasing demand to curb rising incidence rates is also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to an increase in government initiatives coupled with a rise in private investments towards R&D activities pertaining biomarkers testing services. Furthermore, growing awareness regarding early diagnosis among patients is also expected boost regional growth over the next eight years time frame.
In addition, economic development and improvement in healthcare infrastructure are likely to contribute towards increased demand from countries such as India.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyle and dietary habits of people across the world. As a result, there is an increased demand for biomarkers that can help in early diagnosis and treatment of these diseases.
- Advances in technology: Technological advances are helping to develop new and more accurate biomarkers that can be used for diagnosis and treatment of various diseases. This is driving the growth of the ST2 Biomarker market as well as other biomarker markets.
- Growing awareness about biomarkers: There is growing awareness among people about the benefits offered by biomarkers in terms of early diagnosis and treatment of various diseases. This is helping to drive demand for ST2 Biomarkers as well as other types or biomarkers worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
ST2 Biomarker Market Research Report
By Type
ELISA Based ST2 Biomarker, Immunochromatography Based ST2 Biomarker
By Application
Hospitals, Diagnostic Centres, Ambulatory Surgical Centres, Others
By Companies
Thermo Fisher Scientific, BD, Roche, Abbott, Siemens, Bio-Rad, BioMerieux
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global ST2 Biomarker Market Report Segments:
The global ST2 Biomarker market is segmented on the basis of:
Types
ELISA Based ST2 Biomarker, Immunochromatography Based ST2 Biomarker
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Centres, Ambulatory Surgical Centres, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- BD
- Roche
- Abbott
- Siemens
- Bio-Rad
- BioMerieux
Highlights of The ST2 Biomarker Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ELISA Based ST2 Biomarker
- Immunochromatography Based ST2 Biomarker
- By Application:
- Hospitals
- Diagnostic Centres
- Ambulatory Surgical Centres
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the ST2 Biomarker Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
ST2 is a biomarker that is used to measure the risk of developing heart disease.
Some of the major players in the st2 biomarker market are Thermo Fisher Scientific, BD, Roche, Abbott, Siemens, Bio-Rad, BioMerieux.
The st2 biomarker market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 ST2 Biomarker Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 ST2 Biomarker Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 ST2 Biomarker Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the ST2 Biomarker Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global ST2 Biomarker Market Size & Forecast, 2018-2028
4.5.1 ST2 Biomarker Market Size and Y-o-Y Growth
4.5.2 ST2 Biomarker Market Absolute $ Opportunity
Chapter 5 Global ST2 Biomarker Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 ST2 Biomarker Market Size Forecast by Type
5.2.1 ELISA Based ST2 Biomarker
5.2.2 Immunochromatography Based ST2 Biomarker
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global ST2 Biomarker Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 ST2 Biomarker Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Centres
6.2.3 Ambulatory Surgical Centres
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global ST2 Biomarker Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 ST2 Biomarker Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America ST2 Biomarker Analysis and Forecast
9.1 Introduction
9.2 North America ST2 Biomarker Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America ST2 Biomarker Market Size Forecast by Type
9.6.1 ELISA Based ST2 Biomarker
9.6.2 Immunochromatography Based ST2 Biomarker
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America ST2 Biomarker Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Centres
9.10.3 Ambulatory Surgical Centres
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe ST2 Biomarker Analysis and Forecast
10.1 Introduction
10.2 Europe ST2 Biomarker Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe ST2 Biomarker Market Size Forecast by Type
10.6.1 ELISA Based ST2 Biomarker
10.6.2 Immunochromatography Based ST2 Biomarker
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe ST2 Biomarker Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Centres
10.10.3 Ambulatory Surgical Centres
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific ST2 Biomarker Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific ST2 Biomarker Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific ST2 Biomarker Market Size Forecast by Type
11.6.1 ELISA Based ST2 Biomarker
11.6.2 Immunochromatography Based ST2 Biomarker
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific ST2 Biomarker Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Centres
11.10.3 Ambulatory Surgical Centres
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America ST2 Biomarker Analysis and Forecast
12.1 Introduction
12.2 Latin America ST2 Biomarker Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America ST2 Biomarker Market Size Forecast by Type
12.6.1 ELISA Based ST2 Biomarker
12.6.2 Immunochromatography Based ST2 Biomarker
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America ST2 Biomarker Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Centres
12.10.3 Ambulatory Surgical Centres
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) ST2 Biomarker Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) ST2 Biomarker Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) ST2 Biomarker Market Size Forecast by Type
13.6.1 ELISA Based ST2 Biomarker
13.6.2 Immunochromatography Based ST2 Biomarker
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) ST2 Biomarker Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Centres
13.10.3 Ambulatory Surgical Centres
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 ST2 Biomarker Market: Competitive Dashboard
14.2 Global ST2 Biomarker Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 BD
14.3.3 Roche
14.3.4 Abbott
14.3.5 Siemens
14.3.6 Bio-Rad
14.3.7 BioMerieux
